We are live on
!
Find out more
SA
Sovran Advisors Portfolio holdings
AUM
$1.34B
1-Year Est. Return
21.63%
This Fund
S&P 500
This Quarter
Est. Return
+8.46%
1 Year Est. Return
+21.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.13B
AUM Growth
+$177M
(+19%)
Cap. Flow
+$99.2M
Cap. Flow
% of AUM
8.76%
Top 10 Holdings %
Top 10 Hldgs %
19.04%
Holding
555
New
69
Increased
253
Reduced
186
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMNR
BitMine Immersion Technologies
BMNR
|
+$8.11M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$4.63M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$4.57M |
| 4 |
iShares S&P 100 ETF
OEF
|
+$4M |
| 5 |
Apple
AAPL
|
+$3.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$8.35M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$4.14M |
| 3 |
Summit Therapeutics
SMMT
|
+$3.45M |
| 4 |
Meta Platforms (Facebook)
META
|
+$3.41M |
| 5 |
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
|
+$3.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 71.99% |
| 2 | Technology | 10.61% |
| 3 | Healthcare | 3.62% |
| 4 | Financials | 3.32% |
| 5 | Consumer Discretionary | 2.87% |
Similar funds
TIM
AFCM
ACM
DIP
CS
B
LIA
WTA
Sovran Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Sovran Advisors held 555 positions worth $1.13B, up 19% from $954M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Sovran Advisors deployed $99.2M of net new capital in Q3 2025, opening 69 new positions and adding to 253 existing holdings. Its largest new stake was BitMine Immersion Technologies: 160,057 shares worth $7.13M.
By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, down from 73% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $8.35M trimmed.
- Sovran Advisors's largest Q3 2025 buy was BitMine Immersion Technologies: 160,057 shares worth $7.13M.
- Sovran Advisors added most to BlackRock US Equity Factor Rotation ETF in Q3 2025, an estimated $4.63M increase.
- Sovran Advisors's biggest Q3 2025 reduction was Ionis Pharmaceuticals, cutting an estimated $8.35M.
- Sovran Advisors fully exited Summit Therapeutics in Q3 2025, selling an estimated $3.45M.
- Sovran Advisors's ten largest holdings make up 19% of its $1.13B portfolio in Q3 2025.
- Sovran Advisors opened 69 new positions and closed 36 in Q3 2025.
- Sovran Advisors's portfolio value rose 19% quarter-over-quarter to $1.13B.
Based on Sovran Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.